UPDATE: EPO Upholds Molecular Devices Patent with Amendments | GenomeWeb

a GenomeWeb staff reporter

This story has been updated to include comments from Nanion Technologies.

NEW YORK (GenomeWeb News) — The European Patent Office has upheld Molecular Devices' foundation planar patch-clamp patent, but with amendments, ending a dispute filed against the patent by Nanion Technologies.

The ruling is final and cannot be appealed. The EPO will issue a written decision in the near future, Molecular Devices said in a statement issued on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.